Molecules/VISILIZUMAB

VISILIZUMAB

Molecular Identity

AntibodyPhase 3

Mechanism of action: T-cell surface glycoprotein CD3 epsilon chain inhibitor

Molecular Formula

0.00

Molecular Weight

g/mol

huM291HUM-291NUVIONVisilizumabVISILIZUMAB

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to VISILIZUMAB

Loading drug network...